These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24919867)

  • 21. Interim monitoring in sequential multiple assignment randomized trials.
    Wu L; Wang J; Wahed AS
    Biometrics; 2023 Mar; 79(1):368-380. PubMed ID: 34571583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statistical Considerations and Software for Designing Sequential, Multiple Assignment, Randomized Trials (SMART) with a Survival Final Endpoint.
    Kravets S; Ruppert AS; Jacobson SB; Le-Rademacher JG; Mandrekar SJ
    J Biopharm Stat; 2024 Jul; 34(4):539-552. PubMed ID: 37434437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Q-learning: a data analysis method for constructing adaptive interventions.
    Nahum-Shani I; Qian M; Almirall D; Pelham WE; Gnagy B; Fabiano GA; Waxmonsky JG; Yu J; Murphy SA
    Psychol Methods; 2012 Dec; 17(4):478-94. PubMed ID: 23025434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adaptive randomization in a two-stage sequential multiple assignment randomized trial.
    Wang J; Wu L; Wahed AS
    Biostatistics; 2022 Oct; 23(4):1182-1199. PubMed ID: 34052847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficient and robust approaches for analysis of sequential multiple assignment randomized trials: Illustration using the ADAPT-R trial.
    Montoya LM; Kosorok MR; Geng EH; Schwab J; Odeny TA; Petersen ML
    Biometrics; 2023 Sep; 79(3):2577-2591. PubMed ID: 36493463
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dynamic treatment regimes for managing chronic health conditions: a statistical perspective.
    Chakraborty B
    Am J Public Health; 2011 Jan; 101(1):40-5. PubMed ID: 21088260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sample size estimation for comparing dynamic treatment regimens in a SMART: A Monte Carlo-based approach and case study with longitudinal overdispersed count outcomes.
    Yap J; J Dziak J; Maiti R; Lynch K; McKay JR; Chakraborty B; Nahum-Shani I
    Stat Methods Med Res; 2023 Jul; 32(7):1267-1283. PubMed ID: 37167008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identifying a set that contains the best dynamic treatment regimes.
    Ertefaie A; Wu T; Lynch KG; Nahum-Shani I
    Biostatistics; 2016 Jan; 17(1):135-48. PubMed ID: 26243172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imputation of response rates from means and standard deviations in schizophrenia.
    Samara MT; Spineli LM; Furukawa TA; Engel RR; Davis JM; Salanti G; Leucht S
    Schizophr Res; 2013 Dec; 151(1-3):209-14. PubMed ID: 24262679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incorporating participants' welfare into sequential multiple assignment randomized trials.
    Wang X; Deliu N; Narita Y; Chakraborty B
    Biometrics; 2024 Jan; 80(1):. PubMed ID: 38364800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pattern-mixture model approach for handling missing continuous outcome data in longitudinal cluster randomized trials.
    Fiero MH; Hsu CH; Bell ML
    Stat Med; 2017 Nov; 36(26):4094-4105. PubMed ID: 28783884
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methodological Challenges and Statistical Approaches in the COMprehensive Post-Acute Stroke Services Study.
    Psioda MA; Jones SB; Xenakis JG; D'Agostino RB
    Med Care; 2021 Aug; 59(Suppl 4):S355-S363. PubMed ID: 34228017
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Power analysis in a SMART design: sample size estimation for determining the best embedded dynamic treatment regime.
    Artman WJ; Nahum-Shani I; Wu T; Mckay JR; Ertefaie A
    Biostatistics; 2020 Jul; 21(3):432-448. PubMed ID: 30380020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Estimation of optimal dynamic treatment regimes.
    Zhao YQ; Laber EB
    Clin Trials; 2014 Aug; 11(4):400-407. PubMed ID: 24872361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sample size considerations for comparing dynamic treatment regimens in a sequential multiple-assignment randomized trial with a continuous longitudinal outcome.
    Seewald NJ; Kidwell KM; Nahum-Shani I; Wu T; McKay JR; Almirall D
    Stat Methods Med Res; 2020 Jul; 29(7):1891-1912. PubMed ID: 31571526
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome.
    White IR; Joseph R; Best N
    J Biopharm Stat; 2020 Mar; 30(2):334-350. PubMed ID: 31718423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Estimating the optimal dynamic antipsychotic treatment regime: Evidence from the sequential multiple assignment randomized CATIE Schizophrenia Study.
    Shortreed SM; Moodie EE
    J R Stat Soc Ser C Appl Stat; 2012 Aug; 61(4):577-599. PubMed ID: 23087488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A gate-keeping test for selecting adaptive interventions under general designs of sequential multiple assignment randomized trials.
    Zhong X; Cheng B; Qian M; Cheung YK
    Contemp Clin Trials; 2019 Oct; 85():105830. PubMed ID: 31470107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sequential multiple assignment randomized trial studies should report all key components: a systematic review.
    Bigirumurame T; Uwimpuhwe G; Wason J
    J Clin Epidemiol; 2022 Feb; 142():152-160. PubMed ID: 34763037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Get SMART - Understanding Sequential Multiple Assignment Randomized Trials.
    Kim HM
    NEJM Evid; 2023 Apr; 2(4):EVIDe2300031. PubMed ID: 38320015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.